Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: A one-year randomized study of valsartan versus enalapril

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

Hendrik Lehnert, Jens Brøchner‐Mortensen, Ramón Gomis et al. · New England Journal of Medicine · 2001 · 2.9K citations

Medicine, Pharmacology, Pharmacotherapy +17

[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].

Hans‐Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen et al. · PubMed · 2001 · 2.5K citations

Medicine, Pharmacology, Pharmacotherapy +17

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

Anthony Barnett, Stephen C. Bain, Paul Bouter et al. · New England Journal of Medicine · 2004 · 916 citations · Full text

Medicine, Nephrology, Pharmacology +12